NewAmsterdam Pharma Company N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NAMS research report →
About the company
NewAmsterdam Pharma Company N. V. , a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.
- CEO
- Michael Davidson
- IPO
- 2021
- Employees
- 100
- HQ
- Naarden, NH, NL
Price Chart
- Market Cap
- $4.07B
- P/E
- -19.24
- P/S
- 180.45
- P/B
- 6.34
- EV/EBITDA
- -17.01
- Div Yield
- 0.00%
- Gross Margin
- 97.52%
- Op Margin
- -953.59%
- Net Margin
- -942.76%
- ROE
- -29.80%
- ROIC
- -32.35%
- Revenue
- $22.50M · -50.61%
- Net Income
- $-203,819,000 · 15.64%
- EPS
- $-1.75 · 31.64%
- Op Income
- $-225,683,000
- FCF YoY
- 7.04%
- 52W High
- $42.20
- 52W Low
- $19.22
- 50D MA
- $32.73
- 200D MA
- $33.61
- Beta
- 0.08
- Avg Volume
- 1.29M
Get TickerSpark's AI analysis on NAMS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | Kooij Louise Frederika | other | 15,000 |
| Jun 22, 26 | Kooij Louise Frederika | other | 25,000 |
| Jun 22, 26 | Kooij Louise Frederika | other | 25,000 |
| Jun 22, 26 | Kooij Louise Frederika | other | 15,000 |
| Jun 22, 26 | Kooij Louise Frederika | sell | 39,700 |
| Jun 22, 26 | Kooij Louise Frederika | sell | 300 |
| May 26, 26 | Kooij Louise Frederika | other | 5,000 |
| May 26, 26 | Kooij Louise Frederika | other | 60,000 |
| May 26, 26 | Kooij Louise Frederika | other | 60,000 |
| May 26, 26 | Kooij Louise Frederika | other | 5,000 |
Our NAMS coverage
Recent articles, reports, and earnings notes.
No research on NAMS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NAMS report →Similar companies
Peers in the same neighborhood.